Showing results (2271-2280 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|June 18, 2015
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumorsKhanh Do, Giovanna Speranza, Lun-Ching Chang, et al.Investigational New Drugs|June 23, 2015
Targeting the plasma membrane of neoplastic cells through alkylation: a novel approach to cancer chemotherapyMatthew Trendowski, Thomas P FondyInvestigational New Drugs|June 7, 2015
Investigation of the impact of hepatic impairment on the pharmacokinetics of dacomitinibNagdeep Giri, Joanna C Masters, Anna Plotka, et al.Investigational New Drugs|May 4, 2020
The near-infrared fluorescent dye IR-780 was coupled with cabazitaxel for castration-resistant prostate cancer imaging and therapyYu Zheng, Guangdong Hou, Geng Zhang, et al.Investigational New Drugs|May 4, 2020
Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplificationBum Jun Kim, Yoo Jin Kim, Sung-Hwa Sohn, et al.Investigational New Drugs|June 11, 2003
Effect of the antitumor drug vinblastine on nuclear betaII-tubulin in cultured rat kidney mesangial cellsConsuelo Walss-Bass, Jeffrey I Kreisberg, Richard F LudueñaInvestigational New Drugs|June 11, 2003
Reversal of tumor-induced immunosuppression by TGF-beta inhibitorsSlawomir Wojtowicz-PragaInvestigational New Drugs|June 11, 2003
Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administrationMoreno Cocchietto, Sonia Zorzet, Alenka Sorc, et al.Investigational New Drugs|April 1, 1992
Phase II trial of fazarabine in advanced colorectal carcinomaK P Hubbard, K Daugherty, J A Ajani, et al.Investigational New Drugs|April 1, 1992
Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancerR S Walters, R L Theriault, F A Holmes, et al.Pageof 372